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Review
In 2004, bioethicist Michael J. Selgelid decried:
Given the magnitude of the AIDS catastrophe in Africa –
and given that the causes and consequences of this crisis
directly involve issues of justice – it is surprising that, to
date, no major books addressing AIDS in Africa have been
produced by (those who primarily consider themselves to
be) bioethicists. As this is one of the most important
issues of our time, the lack of bioethics literature is unfor-
tunate and reflects poorly on the discipline of bioethics
[1].
Anton A. van Niekerk of the University of Stellenbosch in
South Africa and Loretta M. Kopelman of East Carolina
University in the United States tackle Selgelid's challenge
in their co-edited anthology of articles called, Ethics and
AIDS in Africa: The Challenge to Our Thinking [2].
The book is not only about Africa but, importantly, draws
heavily on the work of African scholars, which is signifi-
cant in a field like bioethics that tends to be dominated by
academics in North America and Europe. The contribu-
tions here and elsewhere from such African scholars as
Godfrey Tangwa, Keymanthri Moodley and Solomon
Benatar are required reading for Western ethicists con-
cerned with international issues and Africa in particular.
Bioethics as a discipline tends to bring together scholars
from a range of fields; so too does this anthology gather
ideas from multiple perspectives including philosophers,
economists and public health specialists. The book grew
out of a special edition of the Journal of Medicine and Phi-
losophy that was guest edited by van Niekerk and Kopel-
man in 2002. Approximately half of the articles in the
current anthology were originally published in that spe-
cial edition, which is a testament to the enduring value of
their ideas four years later but also puts the content at risk
of becoming outdated which is the case in places.
The chapters cover issues ranging from research ethics to
public health ethics to metaethics, and consider the expe-
riences of not only adults, but also children and infants.
Several themes run throughout the book, including the
contrast of 'Western liberalism' with 'Africa communitari-
anism', and the related ethical challenge of balancing risks
to individuals with benefits to society as a whole. How-
ever, no book can do everything; a particular shortcoming
in this book is its insufficient treatment of gender which is
imperative for analysis of the HIV/AIDS pandemic in
Africa.
Most importantly, van Niekerk and Kopelman's anthol-
ogy provides us with a starting point on which to build a
more robust body of scholarship on the ethical dimen-
sions of AIDS in Africa. As noted by Van Niekerk, "HIV/
AIDS is the most serious health and social crisis and chal-
lenge that has ever befallen Africa" (p. 141). Tangwa fur-
ther notes,
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"While the prospect of the possible annihilation of the
entire human race by the HIV/AIDS pandemic is indeed
far-fetched, that of erasing the African continent of its
human inhabitants is not too far from the realm of possi-
bility" (p. 185-6)."
This book is a timely, if not overdue, contribution to the
field.
This review is organized into three sections. First, we pro-
vide an overview and critical analysis of the 13 chapters in
Ethics and AIDS in Africa, highlighting strengths as well as
area for further debate. We then narrow in on particular
themes that have emerged throughout the anthology or
are conspicuous by their absence, such as gender and
human rights. The review finishes with a call for the devel-
opment of a coherent ethical framework for comprehen-
sively conceptualizating the ethical dimensions of AIDS in
Africa and puts forth one possible structure for meeting
this challenge.
Part 1. Overview of chapters
Characterizing the problem: overview of chapters 1 to 3
Despite the promise of ethics in the title of this book, the
reader has to wait until the fifth chapter to encounter
material that explicitly engages ethics theory. In the early
chapters, the authors characterize HIV/AIDS in Africa and
offer economic and pragmatic arguments for what ought
to be done. The link to ethics is an implicit consequential-
ist assumption about the ethical imperative to act effec-
tively, based on which the various authors propose
economic, pragmatic and other arguments to guide
action. In chapters 1 and 2, Whiteside and his colleagues
paint an appropriately grim picture of the pandemic in
Africa and discuss challenges around the use and misuse
of AIDS data.
Chapter 3 is a beautifully argued synopsis of the main
points from Nicoli Nattrass's book, The Moral Economy of
AIDS in South Africa. She presents a compelling economic
argument in favour of the immediate rollout of antiretro-
viral therapy (ART) in South Africa. She also discusses the
catch-22 faced by people living with HIV who rely on
state-sponsored disability grants as their main sources of
income and, thus, dread the loss of those grants by
becoming "too well" on ART. She argues that this horren-
dous choice between wellness and economic support for
one's family can and should be overcome with a shift to a
poverty-oriented basic income grant in South Africa,
which she demonstrates is a feasible economic alternative.
Social and political contexts: overview of chapters 4 and 5
In chapter 4, Anton A. van Niekerk, one of the two co-edi-
tors of the book, continues to set the stage through his
description of selected social complexities that frustrate
the response to HIV/AIDS in Africa. Among the most
interesting contributions of this discussion is a reflection
on how HIV/AIDS can reinforce and exacerbate existing
prejudices about Africa. He reflects on Simon Watney's
claim that:
"... Africa has been effectively demonized in a post-colo-
nial discourse of perpetual catastrophe and unnatural dis-
asters... 'Africans AIDS' thus condenses ancient fears
concerning contagious disease, together with vengeful
fantasies concerning 'excessive' sexuality, understood in
essentially pre-modern terms as both the source and the
cause of AIDS... (p. 59)."
Here, van Niekerk agrees with Loretta M. Kopelman's
argument in chapter 13 regarding the counterproductive
impact of the emphasis on blame and culpability for this
disease, advocating instead that such misconceptions be
abandoned and that energies be refocused on responding
to HIV/AIDS in practical and compassionate ways.
This is also where we are introduced to the theme of the
massive imbalance between wealth in Africa and the West.
Van Niekerk relies heavily on the writing of Solomon Ben-
atar (both here and in his other chapters) to point to the
extraordinary inequity that characterizes this relationship.
Benatar then tackles the issue head-on in chapter 5 where
he identifies HIV/AIDS as a symptom of globalization,
pointing to the kinds of corrections that are required to
address not only HIV/AIDS but a range of other poten-
tially disastrous by-products of the globalizing process.
He notes:
"Structural adjustment programmes, debt repayments,
cuts in foreign aid budgets (especially by the US), discrim-
ination against African trade, increasing malnutrition and
the cold-war activities of the great powers have all played
a significant part in fanning the AIDS pandemic (p. 76)."
Importantly, for the first time in this book, Benatar also
provides an ethics framework for considering these issues.
He suggests that bioethics be expanded to consider three
levels of concern as follows:
￿ micro-level concerns – ethical issues within doctor/
patient and researcher/participant relationships
￿ meso-level concerns – ethical dimensions of order and
justice within communities, including public health and
the social good
￿ macro-level concerns – ethical issues at the level of the
global economy and in relationships between nations
that impact on human well-beingPhilosophy, Ethics, and Humanities in Medicine 2007, 2:1 http://www.peh-med.com/content/2/1/1
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To date, the field of bioethics has focused largely on
micro-level concerns to the exclusion of meso- and
macro-level dimensions. To its credit, this book begins to
redress this shortcoming with almost half of the chapters
exploring what some are calling public health ethics [3], or
the ethical dimensions of concerns with the health of col-
lectives at the meso and/or macro levels. We shall return
to Benatar's three-part framework at the conclusion of our
review to analyze remaining gaps with respect to ethics
and AIDS in Africa.
Engaging with theories of justice: overview of chapter 6
After being lulled into expecting relatively accessible read-
ing on the social and economic dimensions of HIV/AIDS,
chapter 6 can arrive as a shock. Here we shift to a sophis-
ticated engagement with ethics theory which will delight
philosophers and terrify the rest of us that do not have the
benefit of ethics training. This chapter was originally pub-
lished in the South African Journal of Philosophy, which
hints at its orientation. However, for those seeking a con-
cise overview of Rawls' theory of justice as it may be
applied to the global HIV/AIDS pandemic, this chapter is
rewarding. Van Niekerk presents Rawls' theory of justice,
followed by Buchanan's critique of Rawls, followed by his
own critique of both insofar as their principles apply (or
not) to HIV/AIDS in Africa. The result is a rich example of
the kinds of analyses that would strengthen future vol-
umes of this book.
We shall refer readers to the chapter for a full tour of the
ideas; however, there is one controversial point worth
raising here. At risk of oversimplifying, Buchanan argues
that Rawls' ideas about justice (as explicated in his book,
The Law of Peoples) ignores the "global basic structure',
which Buchanan describes as "a set of economic and
political institutions that has profound and enduring
affects on the distribution of burdens and benefits among
peoples and individuals around the world" (p. 96).
Buchanan argues that this global basic structure can
undermine the equality of peoples unless regulated by
global distributive justice, which is in contrast to Rawls'
approach based on charity. Van Niekerk then takes up this
concern, stating: "I see no self-evident reason why the
acceptance and execution of a 'duty of charity' has less of
a moral force than the acceptance and execution of a 'duty
of justice"' (p. 98).
It is our position, however, that the difference between
obligations based on justice and those out of charity are
profound and have dramatic consequences for responses
to HIV/AIDS, particularly when considering the obliga-
tions of rich countries to support the global effort. The
logic underpinning obligations is crucial because it can
bear directly on the action that is subsequently required.
For example, if a rich country is motivated by charity, then
contributions of varying amounts of official development
assistance, typically at well less than 0.7% GDP, can rep-
resent a satisfactory response. However, duties of justice
can lead to different requirements. For instance, political
philosopher Thomas Pogge describes a form of compen-
satory justice that understands moral obligations of rich
nations as deriving from their complicity in the creation
and maintenance of global poverty which fuels epidemics
like HIV/AIDS [4]. As such, resultant actions from this
duty can involve, for instance, redressing economic and
trade policies that limit the capacity of poor countries to
develop. A second critique of the limitations of charity-
based duties is presented by Sckuklenk and Ashcroft
regarding access to essential medicines in chapter 8.
Debates on access to medicine: overview of chapters 7 and 
8
The journey through this anthology gets even more inter-
esting upon arrival at chapter 7 in which David Resnick
(not to be confused with famed HIV denialist David Ras-
nick) tackles the major moral dilemma of insufficient
access to medicines in poor countries. We describe this
chapter as interesting because although Resnick purports
to be analyzing the moral obligations of multinational
pharmaceutical companies, by the end of the chapter his
argument has transitioned into a warning for poor coun-
tries to become better customers by honouring pharma-
ceutical patents or else they may suffer in the long-term.
Resnick begins with a balanced discussion of the role of
big pharma in drug access issues, but then aligns his argu-
ment with the interests of industry by defending current
drug pricing and patents. For example, he argues that: "...
attempts to control or regulate profit margins could have
drastic economic consequences for businesses that would
restrict their ability to contribute to society" (p. 118). This
is a hard claim to swallow for one of the most profitable
industries in history whose 'contributions to society' seem
unrelated in scope to the pattern of their economic gains.
Resnick advocates for poor countries to respect pharma-
ceutical patents. He acknowledges that countries with
public health crises are legally entitled to use the flexibili-
ties within the TRIPS agreement, but warns that this prac-
tice should be regarded "as a last resort" as opposed to a
viable and legal opportunity to save millions of lives. He
discusses ways "... to prevent nations from abusing their
authority to override IPRs under the TRIPS agreement".
However, it is now five years since the historic signing of
the Doha Declaration (which clarified the legitimacy of
public health and human rights trumping intellectual
property rights in cases of emergency) and there remain
worryingly few examples of countries taking advantage of
the provisions. Why might this be? A common answer
involves the asymmetrical power relations that exist
between poor countries on one hand, and rich countriesPhilosophy, Ethics, and Humanities in Medicine 2007, 2:1 http://www.peh-med.com/content/2/1/1
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and their pharmaceutical lobbies on the other. These
dimensions of the problem are not reflected in this chap-
ter.
One final example is illustrative. Resnick argues that:
"It is hard to say exactly how much money pharmaceutical
companies lose as a result of the failure to recognize pat-
ents globally. Industry representatives claim that they lose
as much as ten percent of their profits this way, and it is
likely that drug prices would be lower if the companies
could take advantage of a larger market."
The implication is that drug prices are high because of
markets lost to countries that do not respect patents. How-
ever, the reverse is more à propos: countries take advan-
tage of the flexibilities afforded to them in TRIPs to issue
compulsory licenses or parallel import drugs because the
prices of drugs are prohibitively high.
In chapter 8, Udo Schuklenk and Richard Ashcroft
approach the issue of patents and drug access from an
alternative perspective. Whereas Resnick advised poor
countries against "overriding patents" (p. 124), Schuklenk
and Ashcroft frame the problem of access as worse in
countries that have "restrictive patent laws" (p. 127). In
further contrast to Resnick, they see compulsory licensing
as the key strategy for beginning to reverse the problem of
drug access for Sub-Saharan Africa. They present and reject
three solutions that have been proposed for improving
drug access – (a) donation of drugs from pharmaceutical
companies, (b) price reductions, (c) public-private part-
nerships – before presenting their ethical rationale in
favour of compulsory licensing as the way forward.
They reject both drug donations and price reductions on
the grounds that these arrangements are fraught with con-
ditions and time limits, and rely on the generosity of phar-
maceutical companies for health care planning.
Harkening to our earlier argument, they note a "moral dis-
tinction between charitable giving as voluntary and acting
on duty" (p. 132). A further shortcoming is that the pro-
vider in these arrangements (i.e. the pharmaceutical com-
pany) can stop if the recipient (i.e. the country coping
with an HIV crisis) is perceived to be ungrateful or unde-
serving, which in turn promotes an attitude of humility
toward the giver and limits the ability of the recipient to
set the terms of receipt. As such, Schuklenk and Ashcroft
argue that these approaches are morally problematic for
aretaic reasons related to the motives of the donor and
character of the recipient, and on consequentialist
grounds since they are not sustainable.
They then reject the bulk purchase of medicines through
public-private partnerships because of their lack of success
to date. They note that such efforts initiated by WHO,
UNAIDS and UNICEF have demonstrated a confused
internal logic because, in choosing to work with market
mechanisms (e.g., bulk procurement), the agencies have
assumed an approach that does not challenge industry's
patent regime. However, the role of patents is to create a
monopoly that prevents market mechanisms from work-
ing. Indeed, each of these three solutions accepts that
industry will control the prices of medicines, meaning
that all strategies rely on appeals to the moral obligations
of pharmaceutical companies, which, Schuklenk and Ash-
croft argue, has lead nowhere to date. All rely on charity,
which usually fails us and is not a long-term strategy.
Compulsory licenses, they argue, serve to overcome these
shortcomings. Intellectual property rights are designed to
promote innovation in the public interest, but where they
contravene public interest, this justification disappears.
Schuklenk and Ashcroft propose that IPRs have been used
as a diversion from the real issue of unaffordability of
medicines. They also suggest that too much credence has
been given to concerns about how social acts from moral
obligations can compromise shareholders value and raise
R&D costs without any evidence on the point. They thus
find compulsory licensing to be one of the most impor-
tant initiatives for addressing the gross lack of drug access
in poor countries.
A key strength of anthologies is their capacity to include
contrasting perspectives on a single issue. The dual con-
sideration given to access to medicines in this anthology
made for a more robust and spirited treatment of the sub-
ject. We would have welcomed the editors to have used
this approach more broadly.
Ethical dimensions of research in Africa: overview of 
chapters 9 to 12
In chapter 9, Anton A. van Niekerk provides a welcome
review of the research ethics firestorm that began as a
result of drug trials for prevention of mother-to-child-
transmission (PMTCT) in Africa. In short, in 1994,
researchers in the West demonstrated that a course of the
drug, AZT, could dramatically reduce transmission of HIV
from mother to child. However, the intervention was seen
as prohibitively expensive for poor countries and clini-
cally onerous, requiring a long time to be administered.
Shortly thereafter, condensed regimens of AZT were tested
in poor countries in Asia and Africa and were revealed to
also be successful for PMTCT. Then, an even simpler and
less expensive course of a different drug, Nevirapine, was
demonstrated to be effective. The firestorm was ignited by
an article published by Lurie and Wolfe [5] that
denounced the trials in poor countries as unethical since
they tested the drugs against placebos when the long
course of AZT was already known to be effective. The cen-Philosophy, Ethics, and Humanities in Medicine 2007, 2:1 http://www.peh-med.com/content/2/1/1
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tral debate that emerged and which continues today
involves the issue of the standard of care against which
new interventions should be tested.
Van Niekerk accounts for the divergent views within this
debate by drawing on the fundamental tension in the eth-
ical approaches of deontology and consequentialism.
Whereas deontologists are concerned with the same rules
applying for all and the avoidance of double standards for
rich and poor, consequentialists are concerned with the
path that will provide the greatest justice to all. Van
Niekerk ties this confusion to the appallingly slow rollout
of PMTCT within South Africa drawing on critiques of the
South African political leadership on the issue. We would
also have welcomed a more complete overview of the
debate over standard of care because of its impact on the
field of research ethics as a whole.
Keymanthri Moodley describes HIV vaccine trials as "the
next major ethical challenge in South Africa research cir-
cles" (p. 160) after PMTCT. As such, HIV vaccine trials are
the focus of Moodley's chapter and the two that follow. In
chapter 10, Moodley uses the four principles from the
1979 Belmont Report as a framework for examining HIV
vaccine trial participation in South Africa. Although these
principles – autonomy, beneficence, non-maleficence and
justice – have received almost legendary status as the
dominant ethical framework in bioethics, they were
developed in the West and deserve to be scrutinized for
their utility in African settings. Moodley is also concerned
with the tension that exists between Western orientations
of liberalism and individualism in contrast to African
notions of communitarianism and ubuntu.
Within this context, he provides a useful critique of the
Western approach to informed consent processes for par-
ticipation in HIV vaccine research. Whereas the Western
conceptualization views people as rational, individual
and separate from others, African notions of personhood
are relational, emphasizing reciprocity and interdepend-
ence. Furthermore, Moodley explains, the combination of
illiteracy, language barriers and contrasting belief systems
present a challenge to the competence requirement for
informed consent. As he notes: "Too little protection of
these subjects risks their exploitation; too much protec-
tion risks unjustified paternalism" (p. 167). He argues
that in the aftermath of Apartheid in South Africa, many
people who are competent will still relinquish their deci-
sion-making rights to authority figures. He explains that
power asymmetries are particularly problematic when
researchers and participants are from different racial
groups.
Returning to the issue of HIV vaccine trials in particular,
Moodley argues that the risks of participation outweigh
individual benefits and, thus, that recruitment will largely
rely on contributing to the greater good. However, Mood-
ley warns that the African communitarian nature that sup-
ports such selfless acts is quickly giving way to the
pervasive influence of Western liberalism arriving from all
corners including, ironically, through research processes
like informed consent.
The one chapter presented by an African who is not from
South Africa comes from noted Cameroonian ethicist
Godfrey Tangwa. In chapter 11, he builds on Moodley's
discussion of the differences between Western and African
approaches with new emphasis on the relationship
between health care and business. Whereas they are inti-
mately linked in Western systems, he explains that in
Africa, "medicine and commerce are bad companions" (p.
179). Further, it is an African ideal that no one ought to
die from need, which is antithetical to the Western
approach that the more one needs something, the more
they should pay for it in the classic supply and demand
relationship. Tangwa purports "to search in the 'junk bag',
so to speak, of abandoned or about to be abandoned tra-
ditional Africa values and practices to see whether there
may not be elements" to inform responses to HIV/AIDS in
Africa (p.181). The effort in this chapter goes some dis-
tance to meeting this goal, but a more thorough apprecia-
tion of Tangwa's wisdom on this topic requires a broader
reading of his work. Among Tangwa's greatest gifts is his
use of metaphor, such as this quote with which he ends
his chapter:
"Ethics is about... being unable to sleep with a quiet con-
science should [one's neighbour] happen to die of an ail-
ment whose remedy or part thereof is locked up in one's
cupboard (p. 189)."
In chapter 12, the third discussion of HIV vaccine trials
takes a different slant, examining the issue of enrolling
children in trials. Melissa Stobie, Ann Strode and Cathy
Slack present a coherent and timely analysis of the ethical
and legal dimensions of the 'best interest standard' for
children in South Africa vis-à-vis HIV vaccine trial partici-
pation. By drawing on legal frameworks (e.g., the Consti-
tution of the Republic of South Africa) and ethical
guidelines (e.g., the South Africa Medical Research Coun-
cil's Guidelines of Ethics for Medical Research), they illus-
trate the disjuncture that exists between the paternalistic
protection of specific children versus the anticipated
generic protection of children as a vulnerable population
who deserve special safeguards. This dilemma mirrors the
tension between individual and collective good, and
between deontological and consequentialist approaches
that have been woven throughout the book.Philosophy, Ethics, and Humanities in Medicine 2007, 2:1 http://www.peh-med.com/content/2/1/1
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Ultimately, Stobie et al recommend that the best interest
standard should apply to both individual children and
children as a class, and should be used to balance pater-
nalism with empowerment. To further guide practice, they
present a range of criteria (e.g., age, needs, child's view-
point) that should inform this balancing act.
Revisiting blame: overview of chapter 13
In the final chapter of the anthology, co-editor Loretta M.
Kopelman presents yet another approach to the issue of
ethics and AIDS in Africa by drawing on historical and
biblical ideas embedded in the punishment theory of dis-
ease. She critiques this theory which understands people
as being culpable for acquiring HIV because of sins (in the
religious form) or dubious lifestyles (in the secular form).
Ultimately, and not surprisingly, she discredits this
approach in both its religious and secular forms and
argues that emphasis on this approach to HIV is counter-
productive and undermines the compassionate care for
those in need.
Part 2. Reflecting on emerging themes
The morally dubious response to HIV/AIDS by the South 
African leadership
A recurring theme throughout the anthology (to the point
of redundancy) is critique of the mismanagement of HIV/
AIDS by the South Africa political leadership, and Presi-
dent Thabo Mbeki and Minister of Health Manto Tsha-
balala-Msimang in particular. This repetition can be
explained by at least two factors: first, that the issue itself
is so dire, and second, that 9 of the 13 chapters are
authored by South Africans. However, there are important
insights presented to broaden the opinion of readers who
may only have heard of Mbeki as a morally-questionable
president who queries whether HIV causes AIDS. Rather,
we see Mbeki painted as an outstanding leader helping
South Africa through the difficult post-Apartheid transi-
tion, and for whom AIDS policy has been a bizarre anom-
aly in an otherwise impressive political record. Various
authors provide insight into his baffling stance, drawing
most compellingly on explanations that are located
within historical contexts of Western domination and
imperialism as opposed to explaining away the phenom-
enon as due to a corrupt or uncaring president. Of course,
such explanations do not excuse this behaviour or the pro-
found suffering that it has caused.
To deepen this analysis, we would have appreciated fur-
ther exploration of the by-products of these (in)actions.
For instance, one of us (NN) has found that a central rea-
son for the apathetic response to HIV/AIDS from South
Africa youth leaders (in contrast, for instance, to youth
leadership during the transition from Apartheid in the last
decade) is that statutory youth organizations adopt the
policy platforms of their parent organizations. Thus, the
ANC's abandonment of HIV/AIDS at the highest level has
been mirrored among their youth leaders. However,
South Africa is currently experiencing what appears to be
a sea-change whereby the morally dubious approaches of
President Mbeki and his Minister of Health may be revers-
ing and a new dawn is (possibly) being ushered in for
HIV/AIDS policy.
Insufficient attention to gender concerns
A glaring omission in this book is a sophisticated treat-
ment of the ethical dimensions of gender vis-à-vis AIDS in
Africa. This is not to say that gender is not taken up as an
issue by several authors, but the analyses are narrow at
best (e.g., suggesting that women's disempowerment is
primarily due to insufficient education, p. 63). Further-
more, in keeping with earlier comments about the limited
engagement with ethics theory, there is an absence of fem-
inist ethics perspectives informing our thinking on these
issues.
One final note is that only 3 of the 13 chapters were
authored by women. Tallying gender ratios is not always
a useful exercise, but in the case of AIDS in Africa where
the voices of women have historically been underrepre-
sented, this sort of reflection is essential.
Recognizing Africa's heterogeneity
The fact that this book has been written largely by African
academics is an important contribution for a field that is
dominated by commentators from the West. However, it
is noteworthy that all of the African authors, with one
important exception, are from South Africa and that the
focus of many chapters is the South African experience.
Indeed, there are enough ethical issues complicating AIDS
efforts in South Africa to fill several books, but the stated
aim of this anthology is Africa, which leaves room for fur-
ther reflection.
In a related concern, any discussion of AIDS in Africa risks
homogenizing Africa as if it is one culture experiencing
one HIV epidemic. This is, of course, fully inaccurate.
However, comments such as, "Too little is known about
the culture of African sexual practices and the curbs on
sexual behaviour that would be conducive to the preven-
tion of AIDS" (p. 63), remind us of the need to explicitly
recognize when issues are relevant to Africa broadly (e.g.
destructive effects of odious debt) and when not they are
not (e.g. links between cultural practices and HIV risk).
Undervaluing human rights arguments
A peculiar omission is discussion bridging the contribu-
tion of human rights with ethics in our thinking about
AIDS in Africa. Human rights and ethics share terrain, but
can also offer unique and complementary perspectives in
analyses of HIV/AIDS. The one time that human rightsPhilosophy, Ethics, and Humanities in Medicine 2007, 2:1 http://www.peh-med.com/content/2/1/1
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was invoked in this anthology involved a critique of the
"almost inordinate emphasis" on the right to privacy in
the management of HIV and how this focus may have
inadvertently contributed to further stigmatization of HIV
(p. 64). The author then warns about the danger of
"rights-talk". This perspective is consistent with other crit-
icisms of human rights-based approaches to HIV of late,
especially in the context of testing; that is, whether the vol-
untary counselling and testing that dominates current
thinking and that emerged in the West amidst heightened
concern for protection of human rights is an appropriate
model for generalized epidemics in Sub-Saharan Africa.
What is important in both of these cases is to avoid throw-
ing the baby out with the bathwater. While there may be
shortcomings of overemphasis on the right to privacy, this
should not translate into a full-scale discounting of
human rights-based approaches to HIV in general. There
is a universe of other rights that can contribute to the way
that, for instance, opt-out routine testing is implemented,
or that can promote a response to HIV that is not individ-
ualistic or secretive in nature [6]. In other words, broad
statements about the danger of "rights-talk" are not nearly
as helpful as more specific critiques of rights that recog-
nize both their usefulness and limits in our response to
HIV.
Part 3. Toward a coherent ethical framework on 
AIDS in Africa
It is because the co-editors have provided such a useful
range of insights on the ethics of AIDS in Africa that we are
in the position to reflect on this effort to inform future
work. The topics presented in this anthology have been
diverse at times, overlapping at others, and have indeed
"challenged our thinking" about responses to AIDS in
Africa. A useful next step would be the development of a
coherent framework that unites these oft-disparate
dimensions of the problem; a framework that provides a
mechanism for systematically laying out the range of eth-
ical issues facing AIDS in Africa in a way that is accessible
yet thorough.
By no means are we trying to be reductionist in our
approach to the problem. On the contrary, we are advo-
cating a framework that enables broader reflection on the
topics that are receiving attention as well as those that are
not. Not only could such an ethics framework provide the
basis for identifying a more comprehensive range of
issues, but the framework itself would be open to external-
ist critique for the kinds of perspectives that it excludes,
thus expanding our universe of concern even further.
What might such a framework look like? We propose that
Benatar's micro/meso/macro framework provides an
excellent starting point for mapping out the range of
issues from, for instance, micro-level issues with informed
consent, as discussed by Moodley and Tangwa, to meso-
level concerns regarding the participation of children in
HIV vaccine trials, as discussed by Strode et al, to macro-
level concerns with the impact of globalization on vulner-
ability to HIV/AIDS, as discussed by Benatar. This archi-
tecture serves to reveal not only areas that have been
addressed but, importantly, those that have been
neglected.
At the micro-level, for instance, we are better able to see
that concerns related to the research process have been
explored here, but that ethical dimensions of the clinical
encounter, especially in this era of treatment scale-up,
have been overlooked. Vaccines have been given due
attention, but other prevention technologies, such as
microbicides and circumcision are equally deserving of
ethical scrutiny. Also at the micro-level is an absence of
the voice of people living with HIV regarding the ethical
dilemmas that they face in their lives. One further omis-
sion is an ethical analysis of 'ABC' prevention program-
ming and its usefulness and limits in different settings.
Meso-level concerns with community value systems have
been discussed, but topics such as the rationing of scarce
ART have not. This is also where we might see ethical anal-
yses of the impact of HIV on health systems and the
dilemmas they face in mounting responses, including
issues around health care worker migration. The meso-
level also serves to shine a light on the dicey concern of
cultural practices and their links to HIV.
At the macro-level, global disparities in wealth and health
have been highlighted, but rich countries have largely
escaped moral scrutiny for their role in both helping and
exacerbating the pandemic in Africa through their trade,
economic and development policies. The proliferation of
HIV/AIDS donors is also a topic for ethical analysis with
focus on major players that have emerged in recent years
including the Bill and Melinda Gates Foundation and
PEPFAR. A final suggestion is to focus on the macro-level
issue of global health governance, including the role of
UN agencies.
Beyond the gaps illuminated by this particular ethics
framework, a welcome contribution to conceptualizing
the ethical dimensions of AIDS in Africa would be a cri-
tique of this theoretical approach for the kinds of issues it
privileges and excludes. One such critique could come
from feminist scholars, drawing in particular upon ethics-
in-care approaches to thinking about the pandemic and
responses to date. The point of these various conceptual
framings is not only to give rise to theoretical analysis of
issues, but to a programme of empirical research thatPublish with BioMed Central    and   every 
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examines how issues are being played out (and could or
should be played out) on the ground.
As noted by Selgelid, the ethics of AIDS in Africa is an area
in dire need of study. With Ethics and AIDS in Africa, van
Niekerk and Kopelman provide us with an excellent
springboard for moving toward that goal.
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